Schedule 13D ownership disclosure

Taysha Gene Therapies Inc

Security class unavailable · CUSIP: 877619106

Event date: 2020-09-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
52,953,071
Percent of class
14.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-20-008773
Form type
SC 13D
Filer
Manning Paul B
CIK
CIK 1494695
Filed
Oct 05, 2020
Reporting period
Sep 23, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub